The Institute, led by Dr. Shyam Sathanandam, is transforming neonatal cardiac care by delivering minimally invasive PDA closures directly in the NICU—eliminating transport risks and accelerating recovery for South Florida’s most vulnerable infants....
The Implantable Tibial Neuromodulation (ITNM) device will expand treatment options for the 16 million people living with urinary urges and involuntary leaks...
The COHERENT-AF trial will enrol up to 360 patients across clinical sites in the United States and Europe...
Together, the three devices streamline the procedure by combining effective stone treatment with rapid, controlled clearance...
The outpatient procedures were performed as part of an ongoing FDA IDE clinical trial ...
Expanded indication provides patients with knee osteoarthritis with the benefits of Embosphere’s consistent, predictable, and effective clinical results...
The results of this study suggest that Nexus Spine's patented technology amounts to a significant improvement over the competing devices...
GIP acceptance builds on Neu's FDA clearance for Parkinson's tremor measurement and major U.S. health system pilots with entry into America's largest medical innovation hub...
This collaboration further reinforces Mindray's mission to advance medical technologies to make healthcare more accessible...
Study will begin enrollment in Q1 2026 in the US and UK and leverage the BIOFIRE® SPOTFIRE® point-of-care diagnostics platform at U.S. sites...
